Approval · Notice of Compliance 7906 · 2006
LARGACTIL: Notice of Compliance 7906
Issued April 18, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7906
- Date
- April 18, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Neuroleptic
Products in this notice
Medicinal ingredients
- CHLORPROMAZINE HCL 100 MG per 5ML
- CHLORPROMAZINE HCL 25 MG per 5ML
- CHLORPROMAZINE HCL 40 MG per ML
- CHLORPROMAZINE 100 MG per SUP